Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma

被引：0

作者：

Hualong Zheng

YaJun Zhao

Qingliang He

Hankun Hao

Yantao Tian

Bingbing Zou

Lixin Jiang

Xiantu Qiu

Yanbing Zhou

Zhi Li

Yanchang Xu

Gang Zhao

Fangqin Xue

Shuliang Li

Weihua Fu

Yongxiang Li

Xiaojun Zhou

Yong Li

Zhenggang Zhu

Jinping Chen

Zekuan Xu

Lisheng Cai

En Li

Honglang Li

Jianwei Xie

Chaohui Zheng

Jun Lu

Ping Li

Changming Huang

机构：

[1] Fujian Medical University Union Hospital,Department of Gastric Surgery

[2] Fujian Medical University,Key Laboratory of Ministry of Education of Gastrointestinal Cancer

[3] University of Science and Technology of China,Department of Gastrointestinal Surgery, West District of The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine

[4] The First Affiliated Hospital of Fujian Medical University,Department of Gastrointestinal Surgery

[5] Huashan Hospital,Department of General Surgery

[6] Fudan University,Department of Pancreatic and Gastric Surgery

[7] National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Gastrointestinal Surgery

[8] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Gastrointestinal Surgery

[9] The First Affiliated Hospital of Anhui Medical University,Department of Gastrointestinal Surgery and Gastrointestinal Surgery Research Institute

[10] Yantai Yuhuangding Hospital,Department of Gastrointestinal Surgery

[11] The Affiliated Hospital of Putian University,Department of General Surgery

[12] Affiliated Hospital of Qingdao University,Department of Gastrointestinal Surgery

[13] Henan Cancer Hospital,Department of Gastrointestinal Surgery

[14] Fujian Medicine University Teaching Hospital,Department of Gastrointestinal Surgery

[15] The First Hospital of PuTian,Department of Gastrointestinal Surgery

[16] Renji Hospital,Department of General Surgery

[17] Shanghai Jiaotong University,Department of Gastroenterology Surgery

[18] Provincial Clinical Medical College of Fujian Medical University,Department of General Surgery

[19] Fujian Provincial Hospital,Department of Gastrointestinal Surgery

[20] The Second People’s Hospital of Liaocheng,Department of Gastrointestinal Surgery

[21] Tianjin Medical University General Hospital,Department of General Surgery

[22] The First Affiliated Hospital of Soochow University,Department of General Surgery

[23] Guangdong Provincial People’s Hospital,Department of Gastrointestinal Surgery

[24] Guangdong Academy of Medical Sciences,Department of Gastrointestinal Surgery

[25] Ruijin Hospital Affiliated To Shanghai Jiao Tong University School of Medicine,undefined

[26] Quanzhou First Hospital Affiliated to Fujian Medical University,undefined

[27] The First Affiliated Hospital of Nanjing Medical University,undefined

[28] Zhangzhou Affiliated Hospital of Fujian Medical University,undefined

[29] Meizhou People’s Hospital,undefined

[30] Second Affiliated Hospital,undefined

[31] Nanchang University,undefined

来源：

Gastric Cancer | 2021年 / 24卷

关键词：

Nomogram; Disease-free survival; Gastric neuroendocrine carcinoma; Mixed adenoneuroendocrine carcinoma;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：503 / 514

页数：11

共 68 条

[1]

Maggard MA(2004)Updated population-based review of carcinoid tumors Ann Surg 240 117-122

[2]

O’Connell JB(2017)Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States JAMA Oncol 3 1335-417

[3]

Ko CY(2006)Proposal for a TNM classification of digestive (neuro)endocrine tumors: recommendations of the European Neuroendocrine Tumor Society Annales de Pathol 26 413-1962

[4]

Dasari A(2018)Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study Eur J Surg Oncol 44 1955-401

[5]

Shen C(2006)TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system Virchows Arch 449 395-657

[6]

Halperin D(2013)Are G3 ENETS neuroendocrine neoplasms heterogeneous? Endocr Relat Cancer 20 649-664

[7]

Couvelard A(2015)Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms Endocr Relat Cancer 22 657-160

[8]

Scoazec J(2013)Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study Ann Oncol 24 152-690

[9]

van der Veen A(2015)The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms Am J Surg Pathol 39 683-1470

[10]

Seesing MFJ(2016)Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma Eur J Surg Oncol 42 1464-3072

← 1 2 3 4 5 6 7 →